Primary hyperparathyroidism in MEN 1--how radical should surgery be?

Area of Science:

• Endocrinology
• Surgical Oncology
• Genetics

Background:

• Primary hyperparathyroidism is the most frequent manifestation of Multiple Endocrine Neoplasia type 1 (MEN 1) syndrome.
• The management of MEN 1-associated hyperparathyroidism is challenging due to disease persistence and recurrence.
• Surgical treatment for hyperparathyroidism in MEN 1 is often palliative, requiring careful consideration of long-term outcomes.

Purpose of the Study:

• To outline best practices for surgical management of hyperparathyroidism in MEN 1 patients.
• To emphasize principles of maintaining normocalcemia and avoiding complications.
• To discuss strategies for managing persistent or recurrent hyperparathyroidism in this complex patient group.

Main Methods:

• Comparison of subtotal parathyroidectomy (leaving a <60 mg remnant) versus total parathyroidectomy with immediate autotransplantation.
• Inclusion of central neck fat pad and thymectomy to identify and resect supernumerary or ectopic parathyroid tissue.
• Recommendation for cryopreservation of parathyroid tissue for potential future use.

Main Results:

• Both subtotal parathyroidectomy and total parathyroidectomy with autotransplantation are viable approaches.
• Comprehensive surgical techniques are necessary to address potential ectopic or supernumerary glands.
• Cryopreservation offers a resource for patients requiring reoperation or experiencing hypoparathyroidism.

Conclusions:

• Surgical management of hyperparathyroidism in MEN 1 requires meticulous technique to balance disease control and prevent permanent hypoparathyroidism.
• The chosen surgical approach should aim for long-term normocalcemia and facilitate subsequent interventions if needed.
• Avoiding permanent hypoparathyroidism is crucial, especially in younger patients, as it can be more debilitating than the primary condition.